Morellin



Compound IDCDAMM01427
Common nameMorellin
IUPAC name4-[12-hydroxy-8,8,21,21-tetramethyl-5-(3-methylbut-2-enyl)-14,18-dioxo-3,7,20-trioxahexacyclo[15.4.1.02,15.02,19.04,13.06,11]docosa-4(13),5,9,11,15-pentaen-19-yl]-2-methylbut-2-enal
Molecular formulaC33H36O7

Experimental data

Retention time11.09
Adduct[M+Na]+
Actual mz567.237
Theoretical mz567.235
Error3.85
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.6691

Identifiers and class information

Inchi keyCOQAPWLZSHQTKA-ZDLGFXPLNA-N
SmilesO=CC(=CCC12OC(C)(C)C3CC(C=C4C(=O)C5=C(O)C=6C=CC(OC6C(=C5OC431)CC=C(C)C)(C)C)C2=O)C
SuperclassOrganoheterocyclic compounds
ClassBenzopyrans

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)6
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)544.643
Computed dipole moment(dipole)5.502
Total solvent accessible surface area (SASA)741.282
Hydrophobic component of SASA (FOSA)491.179
Hydrophilic component of SASA (FISA)157.888
Pie component of the SASA (PISA)92.214
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1533.72
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)8
Free energy of solvation of dipole (dip^2/V)0.0197372
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.867654
Predicted polarizability in cubic angstroms (QPpolrz)52.254
Predicted hexadecane/gas partition coefficient (QPlogPC16)14
Predicted octanol/gas partition coefficient (QPlogPoct)22.234
Predicted water/gas partition coefficient (QPlogPw)9.761
Predicted octanol/water partition coefficient (QPlogPo/w)4.42
Predicted aqueous solubility (QPlogS)-5.099
Conformation-independent predicted aqueous solubility (CIQPlogS)-7.794
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.113
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)315.247
Predicted brain/blood partition coefficient (QPlogBB)-1.196
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)142.053
Predicted skin permeability, log Kp (QPlogKp)-3.528
PM3 calculated ionization potential (IP(ev))9.007
PM3 calculated electron affinity (EA(eV))0.891
Number of likely metabolic reactions (#metab)8
Prediction of binding to human serum albumin (QPlogKhsa)0.676
Predicted qualitative human oral absorption (HumanOralAbsorption)2
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)84.59
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)117.009
Number of nitrogen and oxygen atoms (#NandO)7
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q07820MCL1Induced myeloid leukemia cell differentiation protein Mcl-1T14912SwissTargetPrediction
P11926ODC1Ornithine decarboxylaseT60366SEA
O15111CHUKInhibitor of NF-kappa-B kinase (IKK)T78429SwissTargetPrediction
P10599TXNThioredoxinT85616SwissTargetPrediction and SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T14912DI0012Acute myeloid leukaemia[ICD-11: 2A60]Q07820MCL1
T14912DI0245Malignant haematopoietic neoplasm[ICD-11: 2B33]Q07820MCL1
T14912DI0250Mature B-cell lymphoma[ICD-11: 2A85]Q07820MCL1
T14912DI0252Melanoma[ICD-11: 2C30]Q07820MCL1
T14912DI0274Multiple myeloma[ICD-11: 2A83]Q07820MCL1
T14912DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q07820MCL1
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T78429DI0250Mature B-cell lymphoma[ICD-11: 2A85]O15111CHUK
T85616DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P10599TXN

Copyright © 2025